Publications

Browse publications and abstracts demonstrating the accuracy, performance, and real-world impact of our AI solutions.

Featured Publications

Publication

Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19-09, CONPELAN Study

Publication

Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial

 Resources
Journal of sciences and specialties of the head and neck
2026

Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19-09, CONPELAN Study

Author : Sang Hoon Chun, Seyoung Seo, Jang Ho Cho, Keon-Uk Park, Sang-Cheol Lee, Yong Won Choi, Tak Yun, Seong Hoon Shin, Sung-Bae Kim, Seungeun Lee, Chang Ho Ahn, Bhumsuk Keam

Nature Medicine
2026

Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial

Author : Choong-kun Lee, Taek Chung, Il Hwan Kim, Hong Jae Chon, Jin Won Kim, Se Jun Park, Woo Kyun Bae, Junghun Kang, Changhoon Yoo, Dong-Hoe Koo, Sora Kang, Minsuk Kwon, Ju Won Kim, Beodeul Kang, Sejung Park, Woochan Hwang, Chang Ho Ahn, Chang Gon Kim & Hye Jin Choi

Histopathology
2026

Heterogeneity of breast and nodal response to neoadjuvant pembrolizumab-based chemoimmunotherapy in early triple-negative breast cancer and its clinical significance

Author : Jiwon Koh, Koung Jin Suh, Hye Yeon Park, Hyun Jung Kwon, Hyun-Jung Sung, Han Suk Ryu, Jung Ho Kim, Jaemoon Koh, Kyung-Hun Lee, Dae-Won Lee, Changhee Park, Jeongmin Seo, Heejung Chae, Woochan Hwang, Ye Yoon Suh, Chang Ho Ahn, Seock-Ah Im, Jee Hyun Kim, So Yeon Park

Journal for ImmunoTherapy of Cancer
2026

Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors

Author : Mohamed H. Derbala, Bettzy Stephen, Woochan Hwang, Chan-Young Ock, Soohyun Hwang, Joud Hajjar, Seungeun Lee, Jianling Zhou, Serdar A. Gurses, Mohamed A. Gouda, Kathryn E. McGonagle, Anas Alshawa, Lilibeth Castillo, Abdulrazzak Zarifa, Siqing Fu, Sarina A. Piha-Paul, Apostolia M. Tsimberidou, Funda Meric-Bernstam, Luisa Maren Solis Soto, Maria Gabriela Raso, Siraj Ali, and Aung Naing.

ESMO
2026

Artificial intelligence-based prediction of claudin 18.2 expression and immune phenotype from routine histology to guide treatment decisions in patients with gastric cancer

Author : H.-D. Kim, S. Shin, W. Hwang, J. Shin, T. Lee, J. Hyung, J. Park, S. Pereira, C.-Y. Ock, A. Puccini, G. Carloni, Y.S. Park, and M.-H. Ryu

Springer Nature
2026

A comparison of tumour characteristics of screen-detected and interval cancers and their relationship with breast density and AJCC prognostic stage in a UK screening cohort

Author : Fleur Kilburn-Toppin, Joshua Rothwell, Nicholas R. Payne, Yuan Huang, Sarah E. Hickman, Fiona J. Gilbert

 Resources